ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NHS to fund Afinitor for TSC-related epilepsy
January 03, 2019NHS England has announced that from April this year it will fund Novartis' Afinitor (everolimus) for patients living with Tuberous Sclerosis Complex (TSC)-related refractory epilepsy. -
Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with T
February 06, 2017Decision marks the third TSC-related indication for Votubia in the EU.Novartis has announced that the European Commission has approved Votubia (everolimus) dispersible tablets as an adjunctive treatment...
Pharma Sources Insight January 2025
